THIRD AMENDMENT TO SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • September 16th, 2022 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This Third Amendment to Securities Purchase and Security Agreement (this “Amendment”) is entered into as of September 15, 2022 (the “Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), 667, L.P., Baker Bros. Life Sciences, L.P. (each, a “Purchaser”, and collectively, the “Purchasers”), and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity, the “Designated Agent”).
New York, NY 10011Securities Purchase and Security Agreement • March 6th, 2018 • Emmaus Life Sciences, Inc. • Blank checks
Reference is hereby made to that certain Securities Purchase and Security Agreement, dated December 29, 2017 (the “Loan Agreement”), by and between Emmaus Life Sciences, Inc., a Delaware corporation (the “Company”), and GPB Debt Holdings II, LLC (“GPB”). The Company has requested payoff instructions with respect to the repayment in full of the indebtedness and all other obligations including but not limited to principal, accrued and unpaid interest, fees, costs and expenses (collectively, the “Obligations”) under the Loan Agreement as of the date hereof; the only indebtedness owing by the Company to GPB is under the Loan Agreement. Capitalized terms not defined herein shall have the meaning as set forth in the Loan Agreement.
SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • January 25th, 2008 • Metaswarm Inc. • Patent owners & lessors • Massachusetts
SECURITIES PURCHASE AND SECURITY AGREEMENT, dated as of January 22, 2008, between MetaSwarm, Inc., a Florida corporation (the “Issuer”), and AIS Funding, LLC, a Delaware limited liability company (the “Subscriber”).
FIRST AMENDMENT TO SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • November 22nd, 2021 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This First Amendment to Securities Purchase and Security Agreement (this “Amendment”) is entered into as of November 20, 2021 (the “Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), 667, L.P., Baker Bros. Life Sciences, L.P. (each, a “Purchaser”, and collectively, the “Purchasers”), and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity, the “Designated Agent”).
XENONICS HOLDINGS, INC. SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • April 19th, 2006 • Xenonics Holdings, Inc. • Electric lighting & wiring equipment • California
This Securities Purchase and Security Agreement (the “Agreement”) is made and entered into as of April 13, 2006 between Xenonics Holdings, Inc., a Nevada corporation (“Xenonics”), and The Norman Patriot LLC (“Investor”). In consideration of the mutual promises, covenants and conditions hereinafter set forth, the parties hereby agree as follows:
SECOND AMENDMENT TO SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • March 21st, 2022 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This Second Amendment to Securities Purchase and Security Agreement (this “Second Amendment”) is entered into as of March 21, 2022 (the “Second Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), 667, L.P., Baker Brothers Life Sciences, L.P. (each, a “Purchaser”, and collectively, the “Purchasers”), and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity, the “Designated Agent”).
FOURTH AMENDMENT TO SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • September 11th, 2023 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This Fourth Amendment to Securities Purchase and Security Agreement (this “Amendment”) is entered into as of September 8, 2023 (the “Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), 667, L.P., Baker Bros. Life Sciences, L.P. (each, a “Purchaser”, and collectively, the “Purchasers”), and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity, the “Designated Agent”).
SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • April 27th, 2020 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase and Security Agreement (the “Agreement”) is entered into as of April 23, 2020 (the “Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), the Guarantors from time to time party hereto, the purchasers from time to time party hereto (each, a “Purchaser”, and collectively, the “Purchasers”), and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity, the “Designated Agent”).
